home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Brain Cholesterol Metabolism And Alzheimer’s Disease

 
  January, 17 2006 10:16
your information resource in human molecular genetics
 
     
Regulating cholesterol levels in the brain decreases levels of the Amyloid-beta peptide, according to research published this week by the EMBO journal. This peptide is thought to be the causative agent involved in the pathology of Alzheimer's disease.

In the study, by Hasan Mohajeri and colleagues, experiments performed in the mouse brain show for the first time in vivo that interfering with the activity of an enzyme required for the cholesterol production, seladin-1, leads to an increase in Amyloid-beta formation. Conversely, the authors show that increasing seladin-1 levels in cultured human neuroblastoma cells reduces Amyloid-beta levels.

In the normal situation, special cholesterol-rich territories of the membrane physically separate the precursor of Amyloid-beta peptide from the enzymes that are necessary for the generation of the peptide. In the absence of selanin-1, cholesterol levels are low and these territories are disorganized, leaving the enzymes free to process the precursor of Amyloid-beta peptide and form more of the toxic product.

Recent studies have implicated cholesterol metabolism in the pathophysiology of Alzheimer?s disease. The mechanism by which cholesterol modulates the production of the toxic beta-amyloid peptide has however so far remained elusive.

This study nicely confirms that seladin-1 play a crucial role in Amyloid-beta peptide production in vivo, and indicates that pharmacological enhancement of seladin-1 activity may be a novel therapeutic strategy for Alzheimer’s disease.

Author contacts:

Hasan Mohajeri (University of Zurich, Zurich, Switzerland)
E-mail:mohajeri@bli.unizh.ch

Lola Ledesma, (Cavalieri Ottolenghi Scientific Institute, Turin, Italy)
E-mail:lola.ledesma@unito.it

Abstract available online.

(C) EMBO journal press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.